Author

Evdokiya Reshetnikova

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:organoid / primary culture· 1

Frequent Co-Authors

Aharon G. FreudiD· 1 shared Anna E. VilgelmiD· 1 shared Arjun MittraiD· 1 shared Bridget A. OppongiD· 1 shared Dean A Lee· 1 shared Marcelo SF Pereira· 1 shared Nar Bahadur KatuwaliD· 1 shared Vijaya BhartiiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aharon G. FreudORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

CDK4/6 inhibition sensitizes breast cancer to NK cell therapy by inducing immune-interactive surface proteins

Yinchong Wang, Evdokiya Reshetnikova, Nar Bahadur Katuwal, Vijaya Bharti, Marcelo SF Pereira, Bridget A. Oppong, Dean A Lee, Arjun Mittra, Aharon G. Freud, Anna E. Vilgelm

This paper shows CDK4/6 inhibitors make breast cancer cells more susceptible to NK cell therapy by increasing surface proteins that NK cells recognize.

bioRxiv · Apr 22, 2026 · PreprintCancer Biology